These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 33289461)

  • 21. High-throughput virtual screening with e-pharmacophore and molecular simulations study in the designing of pancreatic lipase inhibitors.
    Veeramachaneni GK; Raj KK; Chalasani LM; Bondili JS; Talluri VR
    Drug Des Devel Ther; 2015; 9():4397-412. PubMed ID: 26273199
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In-Silico molecular docking and simulation studies on novel chalcone and flavone hybrid derivatives with 1, 2, 3-triazole linkage as vital inhibitors of Plasmodium falciparum dihydroorotate dehydrogenase.
    Thillainayagam M; Malathi K; Ramaiah S
    J Biomol Struct Dyn; 2018 Nov; 36(15):3993-4009. PubMed ID: 29132266
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Potential inhibitors for FKBP51: an
    Barge S; Jade D; Ayyamperumal S; Manna P; Borah J; Nanjan CMJ; Nanjan MJ; Talukdar NC
    J Biomol Struct Dyn; 2022; 40(24):13799-13811. PubMed ID: 34709133
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Targeting homologous recombination (HR) repair mechanism for cancer treatment: discovery of new potential UCHL-3 inhibitors
    Alakhdar AA; Saleh AH; Arafa RK
    J Biomol Struct Dyn; 2022 Jan; 40(1):276-289. PubMed ID: 32851933
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Revealing the Inhibition Mechanism of RNA-Dependent RNA Polymerase (RdRp) of SARS-CoV-2 by Remdesivir and Nucleotide Analogues: A Molecular Dynamics Simulation Study.
    Wakchaure PD; Ghosh S; Ganguly B
    J Phys Chem B; 2020 Nov; 124(47):10641-10652. PubMed ID: 33190493
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Potential target identification for breast cancer and screening of small molecule inhibitors: A bioinformatics approach.
    Agarwal S; Kashaw SK
    J Biomol Struct Dyn; 2021 Apr; 39(6):1975-1989. PubMed ID: 32186248
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Design, virtual screening, molecular docking and molecular dynamics studies of novel urushiol derivatives as potential HDAC2 selective inhibitors.
    Zhou H; Wang C; Ye J; Chen H; Tao R
    Gene; 2017 Dec; 637():63-71. PubMed ID: 28939339
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification of potential SARS-CoV-2 entry inhibitors by targeting the interface region between the spike RBD and human ACE2.
    Gurung AB; Ali MA; Lee J; Farah MA; Al-Anazi KM
    J Infect Public Health; 2021 Feb; 14(2):227-237. PubMed ID: 33493919
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification and Evaluation of Inhibitors of Lipase from
    Ali S; Khan FI; Mohammad T; Lan D; Hassan MI; Wang Y
    Int J Mol Sci; 2019 Feb; 20(4):. PubMed ID: 30781686
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Unravelling novel congeners from acetyllysine mimicking ligand targeting a lysine acetyltransferase PCAF bromodomain.
    Suryanarayanan V; Singh SK
    J Biomol Struct Dyn; 2018 Dec; 36(16):4303-4319. PubMed ID: 29228881
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification and evaluation of bioactive natural products as potential inhibitors of human microtubule affinity-regulating kinase 4 (MARK4).
    Mohammad T; Khan FI; Lobb KA; Islam A; Ahmad F; Hassan MI
    J Biomol Struct Dyn; 2019 Apr; 37(7):1813-1829. PubMed ID: 29683402
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Multiple e-pharmacophore modelling pooled with high-throughput virtual screening, docking and molecular dynamics simulations to discover potential inhibitors of Plasmodium falciparum lactate dehydrogenase (PfLDH).
    Saxena S; Durgam L; Guruprasad L
    J Biomol Struct Dyn; 2019 Apr; 37(7):1783-1799. PubMed ID: 29718775
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification of novel potential β-N-acetyl-D-hexosaminidase inhibitors by virtual screening, molecular dynamics simulation and MM-PBSA calculations.
    Liu J; Liu M; Yao Y; Wang J; Li Y; Li G; Wang Y
    Int J Mol Sci; 2012; 13(4):4545-4563. PubMed ID: 22605995
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Novel insights into the dynamics behavior of glucagon-like peptide-1 receptor with its small molecule agonists.
    Girdhar K; Dehury B; Kumar Singh M; Daniel VP; Choubey A; Dogra S; Kumar S; Mondal P
    J Biomol Struct Dyn; 2019 Sep; 37(15):3976-3986. PubMed ID: 30296922
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparative Study of Interactions between Human cGAS and Inhibitors: Insights from Molecular Dynamics and MM/PBSA Studies.
    Wang X; Li W
    Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33503880
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacophore model-based virtual screening, docking, biological evaluation and molecular dynamics simulations for inhibitors discovery against
    Naz S; Farooq U; Khan S; Sarwar R; Mabkhot YN; Saeed M; Alsayari A; Muhsinah AB; Ul-Haq Z
    J Biomol Struct Dyn; 2021 Feb; 39(2):610-620. PubMed ID: 31937192
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Shape-based virtual screening, docking, and molecular dynamics simulations to identify Mtb-ASADH inhibitors.
    Kumar R; Garg P; Bharatam PV
    J Biomol Struct Dyn; 2015; 33(5):1082-93. PubMed ID: 24875451
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pantetheinase activity of membrane-bound Vanin-1: lack of free cysteamine in tissues of Vanin-1 deficient mice.
    Pitari G; Malergue F; Martin F; Philippe JM; Massucci MT; Chabret C; Maras B; Duprè S; Naquet P; Galland F
    FEBS Lett; 2000 Oct; 483(2-3):149-54. PubMed ID: 11042271
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identification of novel small molecule non-peptidomimetic inhibitor for prolyl oligopeptidase through
    Shrivastava A; Srivastava S; Malik R; Alam MM; Shaqiquzamman M; Akhter M
    J Biomol Struct Dyn; 2020 Mar; 38(5):1292-1305. PubMed ID: 30929611
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Discovery of multi-target mur enzymes inhibitors with anti-mycobacterial activity through a Scaffold approach.
    Kumari M; Waseem M; Subbarao N
    J Biomol Struct Dyn; 2023 Apr; 41(7):2878-2899. PubMed ID: 35174764
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.